Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 장준 | * |
dc.date.accessioned | 2021-05-24T16:30:03Z | - |
dc.date.available | 2021-05-24T16:30:03Z | - |
dc.date.issued | 2021 | * |
dc.identifier.issn | 1598-2629 | * |
dc.identifier.issn | 2092-6685 | * |
dc.identifier.other | OAK-29192 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/257376 | - |
dc.description.abstract | Adenovirus was originally used as a vector for gene therapy. In recent years, with the development of the next-generation vectors with increased safety and high immunogenicity to transgene products, its utility as a vaccine vector has continued to increase. Adenovirus-based vaccines are currently being tested not only to prevent various infectious diseases but also to be applied as cancer vaccines. In this review, I discuss the innate and adaptive aspects of the immunological characteristics of adenovirus vectors and further examine the current status of advanced adenovirus-based vaccine development. Various methods that can overcome the limitations of currently used adenoviruses as vaccine vehicles are also discussed. Through this study, I hope that vaccine development using adenovirus vectors will be expedited and more successful. | * |
dc.language | English | * |
dc.publisher | KOREA ASSOC IMMUNOLOGISTS | * |
dc.subject | Adenovirus | * |
dc.subject | Genetic vector | * |
dc.subject | Adenovector | * |
dc.subject | Vaccine | * |
dc.title | Adenovirus Vectors: Excellent Tools for Vaccine Development | * |
dc.type | Review | * |
dc.relation.issue | 1 | * |
dc.relation.volume | 21 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.index | KCI | * |
dc.relation.journaltitle | IMMUNE NETWORK | * |
dc.identifier.doi | 10.4110/in.2021.21.e6 | * |
dc.identifier.wosid | WOS:000626257600006 | * |
dc.identifier.scopusid | 2-s2.0-85102753439 | * |
dc.author.google | Chang, Jun | * |
dc.contributor.scopusid | 장준(8735999100) | * |
dc.date.modifydate | 20231120165756 | * |